Chiang T M, Kang E S, Kang A H
Research Service, VA Medical Center, Memphis, TN 38104, USA.
Thromb Res. 1996 Dec 15;84(6):399-409. doi: 10.1016/s0049-3848(96)00208-3.
The binding of type I collagen to its receptor initiates platelet aggregation, but the relationship of the receptor to other signal transduction components is not yet established. Correlation of platelet aggregation and anti-type I collagen receptor antibody immunoprecipitation of type I collagen treated [32PO4]-labeled platelets showed that there are two phosphoproteins (M(r) 53 kDa and 21 kDa) that coprecipitated with the 65 kDa platelet type I collagen receptor. In the present investigation, we have identified one of the phosphoproteins. A soluble component the 100,000x g supernatant fraction of 53 kDa protein is recognized by polyclonal anti-PP1 antibody. The activity of the precipitated phosphatase is inhibited by okadaic acid and inhibitor 1, suggesting that it is protein phosphatase 1 (PP 1). Phosphorylation decreases PP 1 activity as was found with [32PO4]-phosphorylase b as the substrate. The immunocoprecipitation of the type-1 collagen receptor and PP 1 inot the result of cross reactivity of the anti-type I collagen receptor antibody with the PP I protein. These results indicate that the platelet type I collagen receptor, PP 1, and unidentified 21 kDa protein are in close association with the platelet type I collagen receptor upon the binding of type I collagen by the receptor.
I型胶原蛋白与其受体的结合引发血小板聚集,但该受体与其他信号转导成分之间的关系尚未明确。对经[32PO4]标记的I型胶原蛋白处理的血小板进行血小板聚集与抗I型胶原蛋白受体抗体免疫沉淀的相关性研究表明,有两种磷蛋白(分子量53 kDa和21 kDa)与65 kDa的血小板I型胶原蛋白受体共沉淀。在本研究中,我们鉴定出了其中一种磷蛋白。一种可溶性成分,即53 kDa蛋白的100,000×g上清液部分,可被多克隆抗PP1抗体识别。沉淀的磷酸酶活性被冈田酸和抑制剂1抑制,表明它是蛋白磷酸酶1(PP1)。以[32PO4] -磷酸化酶b为底物时,磷酸化会降低PP1活性。I型胶原蛋白受体和PP1的免疫共沉淀并非抗I型胶原蛋白受体抗体与PP1蛋白交叉反应的结果。这些结果表明,当受体与I型胶原蛋白结合时,血小板I型胶原蛋白受体、PP1和未鉴定的21 kDa蛋白紧密相关。